Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Dr Thenmalarchelvi, Associate Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | Drug repurposing for COVID-19 | |
| Commercialization of ‘CIM-Pushti’: Withanolide-A rich, leaf blight tolerant high yielding variety of Ashwagandha (Withania somnifera) with good root textural quality | Dr Tripat Jhang, Scientist, CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Commercialization of high yielding variety of Ashwagandha |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Development of some mammalian cell based models to screen potent leads that might inhibit viral infection | Prof Partha Roy, Indian Institute of Technology (IIT) Roorkee | 2020 | Drug repurposing for COVID-19 | |
| Indian spices and medicinal plants as antiviral against COVID-19 and other related viruses | Prof Vikash Kumar Dubey, Professor, Indian Institute of Technology (IIT), Varanasi | 2020 | Identification of antiviral agents | |
| Designing virus-like particles as vaccine candidates against nCoV-19 Proposed express M (Membrane), N (Nucleocapsid), E (Envelope) and S (Spike) proteins of nCoV-19 simultaneously in HEK293 cells for generating virus-like particle | Prof Manidipa Banerjee, Indian Institute of Technology (IIT) Delhi | 2020 | Vaccine development for COVID-19 | |
| Identifying Possible Potent Inhibitors against COVID-19 via Computational Drug Repurposing Study | Dr Parimal Kar, Assistant Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
| Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pre-clinical validation on non-human primates for heart diseases |
| Plasma Proteomic Analysis of COVID-19 patients to identify the potential biomarkers and therapeutic targets | Dr Sanjeeva Srivastava, Assistant Professor, Indian Institute of Technology (IIT) Bombay, Dr Om Shrivastav, Director, Jaslok Hospital, Mumbai, Dr Jayanthi S Shastri, Professor & Head, T N Medical College & Nair Hospital, Dr Mala Vinod Kaneria, Jaslok Hospital, Mumbai | 2020 | Protein Profiling of COVID patinets | |
| Working on mRNA/peptide-based vaccine for SARS-Cov-2 | Dr Jyotsnendu Giri, Assistant Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | Vaccine development for COVID-19 |